Treatment of a transgenic mouse model of melanoma with tinzaparin, a specific low molecular weight heparin (LMWH), resulted in reduced tumor vascular accumulation of VWF, reduced tumor growth, angiogenesis and metastasis [76]. This evidence concerns the gene VWF and melanoma.